drugset / Trial / NCT01286727
Study to Improve Renal Function After Kidney Transplantation
Phase 2
Unknown
30 enrolled
Angion Biomedica Corp
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of the study is to evaluate the safety and activity of a investigational drug in improving renal function in patients who have undergone renal transplantation and have signs and symptoms of significant renal injury and are at risk for dialysis.
Timeline
- Start
- 2010-02
- Primary completion
- 2015-01
- Completion
- 2016-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | BB3 | Small molecule | — | Intravenous |
Indications
No indication recorded.